在帕金森病的泛肠动性
Alexander Woodcock1, Vanessa Hinson2, Amol Sharma3
1Department of Internal Medicine, Medical College of Georgia, Augusta University, Augusta, Georgia.
Gastroenterology & hepatology
|February 2, 2026
概括
帕金森病 (PD) 通常涉及广泛的肠道功能障碍,而不仅仅是运动症状. 客观测试对于检测影响患者健康的隐藏胃肠道问题至关重要.
科学领域:
- 神经学 神经学
- 胃肠病学 胃肠病学
背景情况:
- 帕金森病 (PD) 是一种进展性神经系统疾病,对生活质量产生重大影响.
- 胃肠道 (GI) 症状,包括动力障碍,在PD患者中非常普遍.
- 报告的症状和客观发现之间的不匹配表明肠-大脑通信受损.
研究的目的:
- 审查帕金森病中胃肠道功能障碍的机制.
- 提供临床评估和关怀PD中的GI问题的框架.
- 强调需要客观评估,而不仅仅是症状报告.
主要方法:
- 在PD中对胃肠道功能障碍的潜在机制的审查.
- 讨论诊断策略,包括视频光学,咳反射测试,高分辨率测量和过境研究.
- 临床评估和护理的框架.
主要成果:
- 皮尔斯顿病涉及整个胃肠道的不运动.
- 许多PD患者有客观的运动性障碍,没有显著的症状.
- 肠道过敏会抑制症状感知,导致诊断不足.
结论:
- 客观评估对于检测PD中未被认可的消化道功能障碍至关重要.
- 识别胰肠动性有助于制定个性化管理策略.
- 积极主动,客观的评估对于全面的PD护理至关重要.
相关概念视频
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Parkinson's Disease: Overview
2.0K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.0K
Physiology of Enteric Nervous System and Gut Health
981
The gastrointestinal tract, responsible for the digestion and absorption of nutrients, is safeguarded by the intestinal barrier, which consists of secretory, physical, and immune components. At the forefront is the secretory barrier, composed of essential elements such as mucus, gut microbiota, and defense proteins. They collaborate to break down food particles, facilitate nutrient absorption, and maintain optimal gut health. These secretory components ensure the smooth functioning of the...
981
Inflammatory Bowel Disease II: Crohn's Disease
1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Immunodeficiency Diseases
2.4K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.4K
Alzheimer's Disease: Treatment
952
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
952


